Breast cancer is recognized as a hormone-dependent malignancy, with increased prolactin concentrations posing a risk factor [9,10].The neurophysiological regulation of prolactin has been found to be controlled by dopamine, and it is also believed to potentially promote breast cancer cell proliferation [11,12]. This evidence concerns the gene PRL and breast carcinoma.